Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anuj Bhargava

Showing results (41-50 of 50) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 50 results.
Diabetes Technology & Therapeutics|March 9, 2022
Evaluation of Extended Infusion Set Performance in Adults with Type 1 Diabetes: Infusion Set Survival Rate and Glycemic Outcomes from a Pivotal TrialRon Brazg, Satish K Garg, Anuj Bhargava, et al.
Diabetes Technology & Therapeutics|October 18, 2023
Two Years with a Tubeless Automated Insulin Delivery System: A Single-Arm Multicenter Trial in Children, Adolescents, and Adults with Type 1 DiabetesAmy B Criego, Anders L Carlson, Sue A Brown, et al.
Diabetes Care|June 8, 2021
Multicenter Trial of a Tubeless, On-Body Automated Insulin Delivery System With Customizable Glycemic Targets in Pediatric and Adult Participants With Type 1 DiabetesSue A Brown, Gregory P Forlenza, Bruce W Bode, et al.
Diabetes Care|December 19, 2015
Risk Factors Associated With Severe Hypoglycemia in Older Adults With Type 1 DiabetesRuth S Weinstock, Stephanie N DuBose, Richard M Bergenstal, et al.
JAMA|June 17, 2020
Effect of Continuous Glucose Monitoring on Hypoglycemia in Older Adults With Type 1 Diabetes: A Randomized Clinical TrialRichard E Pratley, Lauren G Kanapka, Michael R Rickels, et al.
Diabetes Technology & Therapeutics|March 16, 2022
Benefit of Continuous Glucose Monitoring in Reducing Hypoglycemia Is Sustained Through 12 Months of Use Among Older Adults with Type 1 DiabetesKellee M Miller, Lauren G Kanapka, Michael R Rickels, et al.
Frontiers in Endocrinology|January 5, 2026
Automated basal insulin delivery versus multiple daily injections in type 1 diabetes: results from a randomized parallel controlled trialJohan H Jendle, Satish K Garg, Charles Thivolet, et al.
Diabetes Care|December 6, 2024
A Randomized Trial Comparing Inhaled Insulin Plus Basal Insulin Versus Usual Care in Adults With Type 1 DiabetesIrl B Hirsch, Roy W Beck, Martin C Marak, et al.
Diabetes Care|November 12, 2025
INHALE-1: A Multicenter Randomized Trial of Inhaled Technosphere Insulin in Children With Type 1 DiabetesMichael J Haller, Lauren Kanapka, Roshanak Monzavi, et al.
Diabetes Care|July 23, 2024
A Randomized Comparison of Postprandial Glucose Excursion Using Inhaled Insulin Versus Rapid-Acting Analog Insulin in Adults With Type 1 Diabetes Using Multiple Daily Injections of Insulin or Automated Insulin DeliveryIrl B Hirsch, Roy W Beck, Martin Chase Marak, et al.
Pageof 5

Showing results (41-50 of 50) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 50 results.
Diabetes Technology & Therapeutics|March 9, 2022
Evaluation of Extended Infusion Set Performance in Adults with Type 1 Diabetes: Infusion Set Survival Rate and Glycemic Outcomes from a Pivotal TrialRon Brazg, Satish K Garg, Anuj Bhargava, et al.
Diabetes Technology & Therapeutics|October 18, 2023
Two Years with a Tubeless Automated Insulin Delivery System: A Single-Arm Multicenter Trial in Children, Adolescents, and Adults with Type 1 DiabetesAmy B Criego, Anders L Carlson, Sue A Brown, et al.
Diabetes Care|June 8, 2021
Multicenter Trial of a Tubeless, On-Body Automated Insulin Delivery System With Customizable Glycemic Targets in Pediatric and Adult Participants With Type 1 DiabetesSue A Brown, Gregory P Forlenza, Bruce W Bode, et al.
Diabetes Care|December 19, 2015
Risk Factors Associated With Severe Hypoglycemia in Older Adults With Type 1 DiabetesRuth S Weinstock, Stephanie N DuBose, Richard M Bergenstal, et al.
JAMA|June 17, 2020
Effect of Continuous Glucose Monitoring on Hypoglycemia in Older Adults With Type 1 Diabetes: A Randomized Clinical TrialRichard E Pratley, Lauren G Kanapka, Michael R Rickels, et al.
Diabetes Technology & Therapeutics|March 16, 2022
Benefit of Continuous Glucose Monitoring in Reducing Hypoglycemia Is Sustained Through 12 Months of Use Among Older Adults with Type 1 DiabetesKellee M Miller, Lauren G Kanapka, Michael R Rickels, et al.
Frontiers in Endocrinology|January 5, 2026
Automated basal insulin delivery versus multiple daily injections in type 1 diabetes: results from a randomized parallel controlled trialJohan H Jendle, Satish K Garg, Charles Thivolet, et al.
Diabetes Care|December 6, 2024
A Randomized Trial Comparing Inhaled Insulin Plus Basal Insulin Versus Usual Care in Adults With Type 1 DiabetesIrl B Hirsch, Roy W Beck, Martin C Marak, et al.
Diabetes Care|November 12, 2025
INHALE-1: A Multicenter Randomized Trial of Inhaled Technosphere Insulin in Children With Type 1 DiabetesMichael J Haller, Lauren Kanapka, Roshanak Monzavi, et al.
Diabetes Care|July 23, 2024
A Randomized Comparison of Postprandial Glucose Excursion Using Inhaled Insulin Versus Rapid-Acting Analog Insulin in Adults With Type 1 Diabetes Using Multiple Daily Injections of Insulin or Automated Insulin DeliveryIrl B Hirsch, Roy W Beck, Martin Chase Marak, et al.
Pageof 5